Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Non-Hodgkin × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

Rituximab 135 Cyclophosphamide 107 fludarabine phosphate 62 Whole-Body Irradiation 47 Mycophenolic Acid 45 Etoposide 44 fludarabine 41 Peripheral Blood Stem Cell Transplantation 40 Melphalan 39 Busulfan 39 Granulocyte Colony-Stimulating Factor 37 Filgrastim 34 Tacrolimus 32 Vincristine 30 Cyclosporine 28 Prednisone 27 Doxorubicin 27 Antilymphocyte Serum 26 Bendamustine Hydrochloride 25 Methotrexate 23 Cytarabine 23 Lenalidomide 19 Carmustine 19 Bortezomib 18 plerixafor 17 Dexamethasone 17 thymoglobulin 16 Thiotepa 16 Radiotherapy 16 Stem Cell Transplantation 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡